Di Renzo MF - Search Results

1

Di Renzo MF, Corso S. Di Renzo MF, et al. Cancers (Basel). 2020 Dec 15;12(12):3779. doi: 10.3390/cancers12123779. Cancers (Basel). 2020. PMID: 33333972 Free PMC article.

2

MET overexpression turns human primary osteoblasts into osteosarcomas.

Patanè S, Avnet S, Coltella N, Costa B, Sponza S, Olivero M, Vigna E, Naldini L, Baldini N, Ferracini R, Corso S, Giordano S, Comoglio PM, Di Renzo MF. Patanè S, et al. Among authors: di renzo mf. Cancer Res. 2006 May 1;66(9):4750-7. doi: 10.1158/0008-5472.CAN-05-4422. Cancer Res. 2006. PMID: 16651428 Free article.

3

Translational Research in Ovarian Cancer.

Di Renzo MF, Valabrega G. Di Renzo MF, et al. Cancers (Basel). 2020 Dec 8;12(12):3676. doi: 10.3390/cancers12123676. Cancers (Basel). 2020. PMID: 33302341 Free PMC article.

4

Preclinical immunotherapy with Cytokine-Induced Killer lymphocytes against epithelial ovarian cancer.

Capellero S, Erriquez J, Melano C, Mesiano G, Genta S, Pisacane A, Mittica G, Ghisoni E, Olivero M, Di Renzo MF, Aglietta M, Sangiolo D, Valabrega G. Capellero S, et al. Among authors: di renzo mf. Sci Rep. 2020 Apr 15;10(1):6478. doi: 10.1038/s41598-020-63634-z. Sci Rep. 2020. PMID: 32296104 Free PMC article.

5

Xenopatients show the need for precision medicine approach to chemotherapy in ovarian cancer.

Erriquez J, Olivero M, Mittica G, Scalzo MS, Vaira M, De Simone M, Ponzone R, Katsaros D, Aglietta M, Calogero R, Di Renzo MF, Valabrega G. Erriquez J, et al. Among authors: di renzo mf. Oncotarget. 2016 May 3;7(18):26181-91. doi: 10.18632/oncotarget.8325. Oncotarget. 2016. PMID: 27027433 Free PMC article.

6

AKT activation drives the nuclear localization of CSE1L and a pro-oncogenic transcriptional activation in ovarian cancer cells.

Lorenzato A, Biolatti M, Delogu G, Capobianco G, Farace C, Dessole S, Cossu A, Tanda F, Madeddu R, Olivero M, Di Renzo MF. Lorenzato A, et al. Among authors: di renzo mf. Exp Cell Res. 2013 Oct 15;319(17):2627-36. doi: 10.1016/j.yexcr.2013.07.030. Epub 2013 Aug 13. Exp Cell Res. 2013. PMID: 23948303

7

PIM2 kinase is induced by cisplatin in ovarian cancer cells and limits drug efficacy.

Musiani D, Hammond DE, Cirillo L, Erriquez J, Olivero M, Clague MJ, Di Renzo MF. Musiani D, et al. Among authors: di renzo mf. J Proteome Res. 2014 Nov 7;13(11):4970-82. doi: 10.1021/pr500651n. Epub 2014 Aug 15. J Proteome Res. 2014. PMID: 25099161

8

Peritoneal and hematogenous metastases of ovarian cancer cells are both controlled by the p90RSK through a self-reinforcing cell autonomous mechanism.

Torchiaro E, Lorenzato A, Olivero M, Valdembri D, Gagliardi PA, Gai M, Erriquez J, Serini G, Di Renzo MF. Torchiaro E, et al. Among authors: di renzo mf. Oncotarget. 2016 Jan 5;7(1):712-28. doi: 10.18632/oncotarget.6412. Oncotarget. 2016. PMID: 26625210 Free PMC article.

9

PIK3R1^W624R Is an Actionable Mutation in High Grade Serous Ovarian Carcinoma.

D'Ambrosio C, Erriquez J, Arigoni M, Capellero S, Mittica G, Ghisoni E, Borella F, Katsaros D, Privitera S, Ribotta M, Maldi E, Di Nardo G, Berrino E, Venesio T, Ponzone R, Vaira M, Hall D, Jimenez-Linan M, Paterson AL, Calogero RA, Brenton JD, Valabrega G, Di Renzo MF, Olivero M. D'Ambrosio C, et al. Among authors: di renzo mf. Cells. 2020 Feb 14;9(2):442. doi: 10.3390/cells9020442. Cells. 2020. PMID: 32075097 Free PMC article.

10

Cancer Cells Haploinsufficient for ATM Are Sensitized to PARP Inhibitors by MET Inhibition.

D'Ambrosio C, Erriquez J, Capellero S, Cignetto S, Alvaro M, Ciamporcero E, Di Renzo MF, Perera T, Valabrega G, Olivero M. D'Ambrosio C, et al. Among authors: di renzo mf. Int J Mol Sci. 2022 May 21;23(10):5770. doi: 10.3390/ijms23105770. Int J Mol Sci. 2022. PMID: 35628590 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

104 results

Search Page